628 related articles for article (PubMed ID: 30499047)
1. Therapeutic nanoplatforms and delivery strategies for neurological disorders.
Kang YJ; Cutler EG; Cho H
Nano Converg; 2018 Nov; 5(1):35. PubMed ID: 30499047
[TBL] [Abstract][Full Text] [Related]
2. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
Sa P; Singh P; Dilnawaz F; Sahoo SK
Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology-based drug delivery for central nervous system disorders.
Nguyen TT; Dung Nguyen TT; Vo TK; Tran NM; Nguyen MK; Van Vo T; Van Vo G
Biomed Pharmacother; 2021 Nov; 143():112117. PubMed ID: 34479020
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.
Naqvi S; Panghal A; Flora SJS
Front Neurosci; 2020; 14():494. PubMed ID: 32581676
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.
Rhaman MM; Islam MR; Akash S; Mim M; Noor Alam M; Nepovimova E; Valis M; Kuca K; Sharma R
Front Cell Dev Biol; 2022; 10():989471. PubMed ID: 36120565
[TBL] [Abstract][Full Text] [Related]
9. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
10. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
11. Advances in nanomedicines for diagnosis of central nervous system disorders.
Zhang X; Zhou J; Gu Z; Zhang H; Gong Q; Luo K
Biomaterials; 2021 Feb; 269():120492. PubMed ID: 33153757
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.
Cunha S; Amaral MH; Lobo JM; Silva AC
Curr Med Chem; 2016; 23(31):3618-3631. PubMed ID: 27554805
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles-based delivery system and its potentials in treating central nervous system disorders.
Liu T; Xie Q; Dong Z; Peng Q
Nanotechnology; 2022 Aug; 33(45):. PubMed ID: 35917704
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
15. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
[TBL] [Abstract][Full Text] [Related]
16. Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders.
Guo ZH; Khattak S; Rauf MA; Ansari MA; Alomary MN; Razak S; Yang CY; Wu DD; Ji XY
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770950
[TBL] [Abstract][Full Text] [Related]
17. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
19. An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor.
Annu ; Sartaj A; Qamar Z; Md S; Alhakamy NA; Baboota S; Ali J
Front Bioeng Biotechnol; 2022; 10():788128. PubMed ID: 35186901
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
